EXACT Sciences Corporation (EXAS)

NASDAQ
42.65
-0.44(-1.02%)
After Hours
42.71
+0.07(+0.15%)
- Real-time Data
  • Volume:
    420,917
  • Day's Range:
    42.09 - 43.01
  • 52 wk Range:
    29.27 - 89.99

EXAS Overview

Prev. Close
43.09
Day's Range
42.09-43.01
Revenue
1.99B
Open
42.72
52 wk Range
29.27-89.99
EPS
-4.09
Volume
420,917
Market Cap
7.58B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,214,644
P/E Ratio
-10.32
Beta
1.31
1-Year Change
-50.09%
Shares Outstanding
177,684,039
Next Earnings Date
Feb 21, 2023
What is your sentiment on EXACT Sciences?
or
Market is currently closed. Voting is open during market hours.

EXACT Sciences Corporation News

EXACT Sciences Corporation Analysis

EXACT Sciences Corporation Company Profile

EXACT Sciences Corporation Company Profile

Employees
6460

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company’s pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Read More

Analyst Price Target

Average60.65 (+42.20% Upside)
High95
Low35
Price42.65
No. of Analysts17
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellBuyBuySell
Technical IndicatorsStrong SellSellStrong BuyBuyStrong Sell
SummaryStrong SellSellStrong BuyBuyStrong Sell
  • 120 go now
    0
    • For everyone that decided to hold EXAS over night look at the after hours price.
      0
      • The future is now
        0
        • Its about the future of medicine
          0
          • shiotcoin
            0
            • Congratulations on a good pick ;)
              1
              • they took approval from FDA ?
                0
            • Ohio
              0
              • Lesson 1: don't follow worthless "guru" recommendations! Otherwise you lost your money.
                0
                • Bottom! on it's way up...
                  0
                  • I think we hit the bottom yesterday.  This looks like a repeat of last year.  The CEO sells stock before the end of the year and the price plummets with the bears and short sellers getting their way.  I suspect we will begin a rebound today or within the week.  Look out for a great short term opportunity between now and 2/20 when the annual and quarterly report come out.  here is usually a run up in the price before the report as they usually beat their estimates.  Price targets are averaging around 58.
                    2